A Study of NX-019 in Patients with Advanced, Epidermal Growth Factor Receptor (EGFR) Mutant Cancer
A Study of NX-019 in Patients with Advanced, Epidermal Growth Factor Receptor (EGFR) Mutant Cancer
Active, not recruiting · NCT05514496 · Registry updated 2025-03-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of NX-019 in Patients with Advanced, Epidermal Growth Factor Receptor (EGFR) Mutant Cancer | EGFR Mutation-Related Tumors | Active, not recruiting | Phase 1 | 2025-03-11 | NCT05514496 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nalo Therapeutics Inc. | 1 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Asan Medical Center | Seoul | South Korea | 338 |
| City of Hope - Seacliff | Huntington Beach | United States | 4 |
| City of Hope Comprehensive Cancer Center - Duarte | Duarte | United States | 4 |
| City of Hope Orange County Lennar Foundation Cancer Center | Irvine | United States | 21 |
| HealthPartners Cancer Center at Regions Hospital | Saint Paul | United States | 4 |
| HealthPartners Frauenshuh Cancer Center | Saint Louis Park | United States | 4 |
| National Taiwan University Cancer Center | Taipei City | Taiwan | 1 |
| NEXT Virginia | Fairfax | United States | 83 |
| Samsung Medical Center | Seoul | South Korea | 375 |
| Seoul National University Hospital | Seoul | South Korea | 393 |
| Severance Hospital | Seoul | South Korea | 81 |
| University of Virginia Comprehensive Cancer Center | Charlottesville | United States | 11 |